Abstract
A single dose of pegfilgrastim or the daily administration of colony-stimulating factors can be used to prevent febrile neutropenia. This may delay the detection of rapidly progressive infections among cancer patients undergoing chemotherapy. We report a case of Pseudomonas aeruginosa bacteremic pneumonia that occurred in a patient receiving pegfilgrastim.
| Original language | English |
|---|---|
| Pages (from-to) | 2039-2042 |
| Number of pages | 4 |
| Journal | Internal Medicine |
| Volume | 56 |
| Issue number | 15 |
| DOIs | |
| Publication status | Published - 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Internal Medicine
Fingerprint
Dive into the research topics of 'The first case of pseudomonas aeruginosa bacteremic pneumonia in a cancer patient receiving pegfilgrastim'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver